Top Midday Stories: Cigna Won't Pursue Combination With Humana; AbbVie Phase 2 Schizophrenia Drug Trials Fail to Meet Primary Endpoints

MT Newswires Live
2024-11-12

All three major US stock indexes were up in late-morning trading Monday, as the post-election rally continues.

In company news, Cigna Group (CI) said Monday it is not pursuing a combination with Humana (HUM), and it expects to communicate that to investors and analysts in meetings over the next several weeks. Shares of Cigna were up 7% around midday, while those of Humana were down 4.4%.

AbbVie (ABBV) said Monday that two phase 2 trials assessing emraclidine in adult patients with schizophrenia and acute exacerbation of psychotic symptoms didn't meet their primary goal. The primary endpoint was an improvement in the change from baseline in the Positive and Negative Syndrome Scale score compared with the placebo group at week six, the company said. Shares of AbbVie were down 11.3%.

MicroStrategy (MSTR) said Monday it increased its bitcoin portfolio to 279,420 as of Nov. 10. The company purchased around 27,200 bitcoins for nearly $2.03 billion in cash during the period from Oct. 31 to Nov. 10 at an average price of about $74,463 per bitcoin, inclusive of fees and expenses. Shares of MicroStrategy were up 19.0%.

Dell Technologies' (DELL) artificial intelligence infrastructure momentum is building "even faster" as more than $20 billion of AI server revenue is anticipated for the company in fiscal 2026, Morgan Stanley said Monday in a note. Morgan Stanley expects the company to ship 48,000 8-GPU AI server equivalents in fiscal 2026, representing 23% growth year over year, the note said. Additionally, Morgan Stanley said that Super Micro Computer's (SMCI) recent challenges represent a "key opportunity" for Dell to gain "incremental share" in fiscal 2026 and unlock an "AI server bull case." Shares of Dell were up 0.9%, while those of Super Micro Computer were down 8.5%.

Price: 342.06, Change: +22.29, Percent Change: +6.97

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10